Cite
Patoulias D, Boulmpou A, Papadopoulos CE, et al. Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?. Kidney Med. 2021;3(4):674-675doi: 10.1016/j.xkme.2021.02.014.
Patoulias, D., Boulmpou, A., Papadopoulos, C. E., & Doumas, M. (2021). Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?. Kidney medicine, 3(4), 674-675. https://doi.org/10.1016/j.xkme.2021.02.014
Patoulias, Dimitrios, et al. "Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?." Kidney medicine vol. 3,4 (2021): 674-675. doi: https://doi.org/10.1016/j.xkme.2021.02.014
Patoulias D, Boulmpou A, Papadopoulos CE, Doumas M. Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?. Kidney Med. 2021 Jun 26;3(4):674-675. doi: 10.1016/j.xkme.2021.02.014. eCollection 2021. PMID: 34401735; PMCID: PMC8350837.
Copy
Download .nbib